The FDA has outlined four ways it plans to improve the medical device postmarket surveillance system.
The four strategies outlined include the following:
Establish a unique device identification system and promote its incorporation into electronic health information
Promote the development of national and international device registries for selected products
Modernize adverse event reporting and analysis
Develop and use new methods for evidence generation, synthesis and appraisal
The FDA will host four public meetings this month to garner public feedback....
